Vanderbilt Basic Sciences

  Walter Chazin, Ph.D., received a B.Sc. in chemistry from McGill University in 1975 and a Ph.D. in chemistry from Concordia University in Montreal in 1983. He was a postdoctoral fellow in the lab of Kurt Wüthrich at the E.T.H. in Switzerland (2002 Nobel laureate in Chemistry). After 13… Read More

A research endeavor that seeks to develop a new cancer immunotherapy utilizing nanobody delivery and targeted heating of tumors has received funding from the Waddell Walker Hancock Cancer Discovery Fund. Read More

A Vanderbilt graduate student and two members of the Meharry-Vanderbilt Alliance joined the Endocrine Society’s leadership program, which provides scientists with leadership development, expanded skills in hands-on training, and networking opportunities with endocrinology leaders. Read More

Stachowiak is recognized for a paradigm-shifting discovery in the field of membrane biophysics, demonstrating that proteins can induce membrane curvature solely through a surface-crowding mechanism. Her lab investigates the biophysical mechanisms that underlie the function of lipid membranes in cells and explores the opportunity of creating bio-inspired materials and systems that borrow these mechanisms. Read More

High school student Benjamin Gordon, former Marnett lab intern, has been named a top scholar in the Regeneron Science Talent Search 2024, the oldest science and math competition for high school seniors in the U.S. Read More

Machine learning and OpenFold authority Mohammed AlQuraishi to present the Vanderbilt Basic Sciences Apex Lecture on January 29. Read More

Researchers in the lab of Vivian Weiss, assistant professor of pathology, microbiology, and immunology, recently published a review article in Cancer Research that describes the role of the Wnt pathway in TAMs and tumor biology. Read More

The School of Medicine Basic Sciences and the Office of the Vice Provost for Research and Innovation launch the Innovation Ignition Fund. This pilot program offers up to $500,000 in funding and drug development mentorship from Vanderbilt scientists with expertise in translational research. Read More

In a collaborative effort co-led by teams from Vanderbilt University Medical Center (VUMC) and the University of Michigan, a comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. The study, published Dec. 4 in… Read More

A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark.  “Vanderbilt is proud that a discovery by our researchers at the Warren Center… Read More